Dr. Danuta Trzebinska, MD

Dr. Trzebinska practices at Oceanside Dialysis in La Jolla, California.

Dr. Trzebinska's NPI, 1629125042, was assigned on January 5, 2007. Dr. Trzebinska graduated from Harvard Medical School in 1999. Dr. Trzebinska's California license number on file is A78916.

Dr. Trzebinska's primary practice is Oceanside Dialysis, at 4225 Executive Sq, La Jolla, CA 92037 in San Diego County. The practice phone is (760) 941-8393.

Dr. Trzebinska's primary practice is Oceanside Dialysis in La Jolla, California. Dr. Trzebinska is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trzebinska practices. Vendor and product names are available with a free account.

Nephrology is Dr. Trzebinska's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Trzebinska is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Trzebinska's licenses on file in 15 states: California, South Dakota, Ohio, Hawaii, Colorado, North Carolina, New Jersey, New Mexico, Oregon, South Carolina, Alaska, District of Columbia, Florida, Georgia and Iowa.

Dmand AI lists chronic kidney disease among the conditions Dr. Trzebinska treats.

CMS data shows 168 Medicare services from Dr. Trzebinska across 5 procedure codes in 2024, for 72 Medicare patients. Medicare paid $13,302 for them.

CMS counts 72 Medicare patients who saw Dr. Trzebinska in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 40% are also on Medicaid. Their average risk score is 4.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trzebinska's median patient age at 63, with 43% women.

In 2024, Dr. Trzebinska wrote 209 Medicare Part D claims for 38 patients. 83% of them were for generic drugs. CMS names the drug for 104 of them, across 6 drugs with 11 or more claims each, at $18,990 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

Dr. Trzebinska accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Trzebinska, published from 2018 to 2021. 2018 was the busiest year, with 2. The most frequent topics are Kidney Failure, Chronic and Renal Dialysis. Dr. Trzebinska's most frequent co-authors are Alexander Lionel Bullen, MD, Tushar A. Chopra, MD and Pranav Sandilya Garimella, MD.

Dmand AI links Dr. Trzebinska to 1 clinical trial. Conditions studied include Kidney Failure, Chronic and Renal Insufficiency, Chronic.

CMS Open Payments shows 6 general payments to Dr. Trzebinska from 5 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 87% of the total. Fresenius USA Marketing, Inc. paid the most, $35.

Dr. Trzebinska graduated from Harvard Medical School in 1999.

Dr. Trzebinska is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.